Medtronic reports third quarter fiscal 2024 financial results
/CNW/ -- Medtronic plc (NYSE:MDT) today announced financial results for its third quarter (Q3) of fiscal year 2024 (FY24), which ended January 26, 2024. Key...
Stay updated with breaking news from Structural Heart. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/CNW/ -- Medtronic plc (NYSE:MDT) today announced financial results for its third quarter (Q3) of fiscal year 2024 (FY24), which ended January 26, 2024. Key...
THE NEW Montefiore Structural Heart Program at White Plains Hospital provides patients with the most advanced procedures for heart valve.
Emory Heart & Vascular reached a significant historic milestone, performing a Transcatheter Aortic Valve Replacement (TAVR) procedure on its 5,000th patient at the end of last year. Emory's history with the innovative, minimally invasive procedure goes back all the way to 2007, when it became the first site in Georgia (and one of the first in the nation) to perform it.
Edwards Lifesciences today reported financial results for the quarter ended December 31, 2023. Highlights and Outlook Q4 sales grew 14 percent to $1.53 billion; constant currency1 sales grew 13...
Edwards Lifesciences (NYSE:EW) announced today that the FDA granted approval for its Evoque tricuspid valve replacement system.